Crispr Therapeutics Ag (CRSP)

11:30 AM

CRISPR Therapeutics (CRSP) Up 11.1% Since Last Earnings Report: Can It Continue? - Yahoo

11:30 AM

06:59 AM

CRISPR Therapeutics AG (NASDAQ:CRSP) Stake Raised by Green Alpha Advisors LLC - MarketBeat

06:59 AM

Jun 04, 2025

Can CRISPR Build on Casgevy's Success With Its In Vivo Pipeline? - Yahoo Finance

Jun 04, 2025

Jun 03, 2025

Promising Growth and Diversification Drive Buy Rating for Crispr Therapeutics AG - TipRanks

Jun 03, 2025

Jun 03, 2025

Can CRISPR Build On Casgevy's Success With Its In Vivo Pipeline? - Barchart.com

Jun 03, 2025

Jun 03, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Sold by Voloridge Investment Management LLC - MarketBeat

Jun 03, 2025

Jun 03, 2025

The Best Stocks to Invest $1,000 in Right Now - The Motley Fool

Jun 03, 2025

Jun 03, 2025

Capital Market Strategies LLC Buys 9,652 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Jun 03, 2025

Jun 03, 2025

Q2 EPS Forecast for CRISPR Therapeutics Increased by Analyst - MarketBeat

Jun 03, 2025

Jun 03, 2025

Insider Selling: CRISPR Therapeutics AG (NASDAQ:CRSP) Insider Sells 3,932 Shares of Stock - MarketBeat

Jun 03, 2025

Jun 02, 2025

Cas9 Technology Market Projected to Hit $30.4 Billion at a 19.81% CAGR by 2032 - industrytoday.co.uk

Jun 02, 2025

Jun 02, 2025

The 2 Smartest Beaten-Down Biotech Stocks to Buy on the Dip - Yahoo Finance

Jun 02, 2025

Jun 01, 2025

Trading (CRSP) With Integrated Risk Controls - news.stocktradersdaily.com

Jun 01, 2025

Jun 01, 2025

Top 5 CRISPR Companies To Invest In (June 2025) - Securities.io

Jun 01, 2025

May 31, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat

May 31, 2025

May 31, 2025

Zacks Research Has Positive Outlook for CRSP Q2 Earnings - Defense World

May 31, 2025

May 30, 2025

Two Sigma Advisers LP Buys 28,400 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

May 30, 2025

May 30, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) Receives $71.75 Consensus Target Price from Analysts - MarketBeat

May 30, 2025

May 29, 2025

ARK Investment Expands Stake in Crispr Therapeutics (CRSP) | CRS - GuruFocus

May 29, 2025

May 29, 2025

ARK Investment Expands Stake in Crispr Therapeutics (CRSP) | CRSP Stock News - GuruFocus

May 29, 2025

May 29, 2025

Cathie Wood’s ARK Investment buys 294K shares of Crispr Therapeutics today - TipRanks

May 29, 2025

May 29, 2025

ARK Investment Increases Stake in Crispr Therapeutics (CRSP) | CRSP Stock News - GuruFocus

May 29, 2025

May 29, 2025

CRISPR Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire

May 29, 2025

May 29, 2025

Two Sigma Investments LP Grows Stock Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

May 29, 2025

May 28, 2025

Crispr Therapeutics, Clover Health among healthcare stocks to join Russell 3000; INO, SAVA to exit - Seeking Alpha

May 28, 2025

May 28, 2025

CRISPR and Cas Genes Market Set to Witness Significant Growth - openPR.com

May 28, 2025

May 27, 2025

Cathie Wood’s ARK Investment buys 262K shares of Crispr Therapeutics today - TipRanks

May 27, 2025

May 27, 2025

Ameriprise Financial Inc. Acquires 18,412 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

May 27, 2025

May 27, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World

May 27, 2025

May 26, 2025

Westwood Holdings Group Inc. Raises Stake in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

May 26, 2025

May 26, 2025

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know - MSN

May 26, 2025

May 25, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Stock Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

May 25, 2025

May 25, 2025

CRISPR Therapeutics' (CRSP) "Market Outperform" Rating Reiterated at JMP Securities - MarketBeat

May 25, 2025

May 25, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Earns "Buy" Rating from HC Wainwright - MarketBeat

May 25, 2025

May 24, 2025

CRISPR Therapeutics’ SWOT analysis: gene-editing pioneer’s stock faces pivotal year - Investing.com Nigeria

May 24, 2025

May 24, 2025

Q2 EPS Estimate for CRISPR Therapeutics Decreased by Analyst - MarketBeat

May 24, 2025

May 24, 2025

Rafferty Asset Management LLC Lowers Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

May 24, 2025

May 23, 2025

Northern Trust Corp Has $10.12 Million Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

May 23, 2025

May 23, 2025

Cetera Investment Advisers Reduces Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - Defense World

May 23, 2025

May 23, 2025

Q2 EPS Estimate for CRISPR Therapeutics Lowered by Analyst - Defense World

May 23, 2025

May 23, 2025

Transcript : CRISPR Therapeutics AG Presents at H.C. Wainwright 3rd Annual BioConnect Investor Conference 2025, May-20-2025 04 - marketscreener.com

May 23, 2025

May 22, 2025

Transcript : CRISPR Therapeutics AG Presents at RBC Capital Markets Global Healthcare Conference 2025, May-20-2025 10 - marketscreener.com

May 22, 2025

May 22, 2025

CRSP July 3rd Options Begin Trading - Nasdaq

May 22, 2025